Skip to search formSkip to main contentSkip to account menu

Malignant neoplasm of stomach stage III

Known as: Stage III Gastric Cancer, Stage III Gastric Cancer AJCC v7, gastric cancer, stage III 
Stage III includes: IIIA (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0); IIIB (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0); IIIC (T4b, N2, M0… 
National Institutes of Health

Related topics

Related topics

10 relations
Epithelial CellsEpitheliumGastric mucosaGastrointestinal system

Narrower (1)

Stage III Carcinoma of Stomach

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial).
4007Background: Although postoperative adjuvant chemotherapy with S-1 is among the standard treatments for curatively resected… 
2018
2018
Prognostic value of preoperative prognostic nutritional index in stage III gastric cancer after curative resection: a retrospective cohort study.
BACKGROUND AND OBJECTIVES Nutrition and inflammation play a crucial role in the development of cancer. The prognostic value of… 
2018
2018
A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
Background/Aim: The aim of this phase I/II study was to determine the safety, and efficacy of combination of neoadjuvant… 
2017
2017
Comparison of the 7th and 8th editions of the American joint committee on cancer TNM classification for patients with stage III gastric cancer.
BACKGROUND AND OBJECTIVES The eighth TNM edition for gastric cancer was released in 2016 and included major revisions, especially… 
2017
2017
Comparison of the 7th and 8th editions of the American joint committee on cancer TNM classification for patients with stage III gastric cancer
Background and Objectives The eighth TNM edition for gastric cancer was released in 2016 and included major revisions, especially… 
2017
2017
699PThe effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of stage III gastric cancer patients: A comparative study between the 7th and 8th…
2016
2016
Expression of tumor necrosis factor-α-induced protein 8 in stage III gastric cancer and the correlation with DcR3 and ERK1/2.
Tumor necrosis factor (TNF)-α-induced protein 8 (TIPE) is a recently identified protein that is considered to be associated with… 
2016
2016
An update on the randomized phase III POST trial: S-1 based doublet as an adjuvant chemotherapy for curatively resected stage III gastric cancer.
4042Background: We report an updated results from a randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS… 
2011
2011
Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy
Objective: The aim of this prospective study was to evaluate the feasibility and safety of adjuvant S-1 plus docetaxel in… 
1988
1988
STUDY ON THE EFFECT OF POST-OPERATIVE ADJUVANT CHEMOTHERAPY FOR THE PATIENTS WITH STAGE III GASTRIC CANCER
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)